Atezolizumab addition to chemotherapy after surgery does not improve survival for triple negative breast cancer: Study
by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with triple-negative breast cancer do not benefit from the addition of atezolizumab to their pos
Updated on: March 28,2024
0
Atezolizumab addition to chemotherapy after surgery does not improve survival for triple negative breast cancer: Study
by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainPatients with triple-negative breast cancer do not benefit from the addition of atezolizumab to their pos
Updated on:March 28,2024
0